You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 1, January 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Multiple Sclerosis/ Demyelinating Disease
 •Radiologic Imaging
 •Magnetic Resonance Imaging
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Rethinking Multiple Sclerosis

Arch Neurol. 2001;58:30-32.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE STUDY of multiple sclerosis (MS) has been one of the more active and rewarding areas of neurological research in the last quarter of the 20th century. Viewed as the pathological consequence of a partially dysregulated immune response turned against certain myelin components, MS has recently joined the growing forefront of neurological illnesses for which disease-modifying treatments are now available. Yet, the continued advancement of better and more effective therapies relies on a better understanding of the pathological basis of MS, especially in relation to its associated neurological consequences.

The most apparent aspects of MS in most individuals are relapses and a subsequent irreversible worsening (progression) of neurological deficits. Generally, clinical relapses have been considered to be associated with sporadic focal inflammatory events within clinically eloquent areas of the brain and spinal cord, while the sustained progression of clinical disability has been associated with accumulated, relapse-associated, focal myelin and axonal . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

What Causes Multiple Sclerosis to Worsen?
Phillips
Arch Neurol 2007;64:167-168.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.